HHS lets compounding pharmacies make six unapproved peptides
HHS will let compounding pharmacies make and sell six peptides the FDA hasn't approved, a move CBS News ties to Secretary Robert F. Kennedy Jr.
The Department of Health and Human Services will let compounding pharmacies make and sell six peptides that the Food and Drug Administration has not approved. The Hill and NPR both reported it.
CBS News describes the move as part of a push by HHS Secretary Robert F. Kennedy Jr. for pharmacies to produce non-FDA-approved peptides. The CBS report in hand is a short segment description and gives no further detail.
HHS said in a notice that it would use enforcement discretion, according to The Hill. The Hill reports the department did not finalize any new approvals or regulatory changes. It says the announcement came on Wednesday.
The Hill says the peptides are ones championed under the "Make America Healthy Again" agenda and had not been added to the list of approved substances. NPR says the permission covers small compounding pharmacies.
NPR reports the arrangement may not be enough to meet demand.
Reported by
- The HillHHS to allow sale of unapproved peptides under reviewWed, Oct 28, 2:18 PM EDT
- The HillHHS gives compounding pharmacies free rein to make certain peptidesWed, Oct 28, 6:11 PM EDT
- NPRTrump administration will allow pharmacies to make popular peptidesWed, Oct 28, 6:26 PM EDT
- CBS NewsInside RFK Jr.'s push for pharmacies to make non-FDA approved peptidesThu, Oct 29, 10:22 AM EDT
This story was written by AI using only the reports listed above, and published without a person reviewing it first. It is rewritten as new reports arrive. Read the original reporting for full detail. Spot an error? Tell us.
Earlier versions (1)
- Wed, Oct 28, 6:30 PM EDT, 2 outlets: HHS lets compounding pharmacies make six unapproved peptides